Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?

@article{Rainov2007ExperimentalTF,
  title={Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?},
  author={N. Rainov and Y. Tsuboi and P. Krolak-Salmon and A. Vighetto and K. Doh-Ura},
  journal={Expert Opinion on Biological Therapy},
  year={2007},
  volume={7},
  pages={713 - 726}
}
  • N. Rainov, Y. Tsuboi, +2 authors K. Doh-Ura
  • Published 2007
  • Medicine
  • Expert Opinion on Biological Therapy
  • Human transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are caused by the accumulation of an abnormal isoform of the prion protein in the CNS. Creutzfeldt-Jakob disease in its sporadic form is the most frequent type of human TSE. At present, there is no proven specific or effective treatment available for any form of TSE. Pentosan polysulfate (PPS) has been shown to prolong the incubation period when administered to the cerebral ventricles in a rodent TSE model… CONTINUE READING
    33 Citations
    Continuous intraventricular infusion of pentosan polysulfate: Clinical trial against prion diseases
    • 90
    Creutzfeldt‐Jakob disease: hopes for therapy
    • 10
    [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
    • 1
    Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases
    • 7
    • PDF
    Protease‐resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion
    • H. Honda, K. Sasaki, +4 authors T. Iwaki
    • Medicine, Biology
    • Neuropathology : official journal of the Japanese Society of Neuropathology
    • 2012
    • 24
    [Innovation of therapeutics and prophylaxis for prion diseases].
    • K. Doh-ura
    • Medicine
    • Rinsho shinkeigaku = Clinical neurology
    • 2009
    • 1

    References

    SHOWING 1-10 OF 94 REFERENCES
    Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    • 72
    Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies
    • 126
    Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
    • 1,922
    Treatment of Transmissible Spongiform Encephalopathy by Intraventricular Drug Infusion in Animal Models
    • 194
    • Highly Influential
    • PDF
    Pathology of variant Creutzfeldt-Jakob disease.
    • J. Ironside
    • Medicine
    • Archives of virology. Supplementum
    • 2000
    • 33
    • PDF
    A systematic review of prion therapeutics in experimental models.
    • 234
    • PDF
    Evaluation of Quinacrine Treatment for Prion Diseases
    • 180
    • PDF
    The molecular biology of prion propagation.
    • 57